GH - CIK 0001576280
Guardant Health, Inc. trades as GH and has a market capitalization of $17.33 B, making it the #671 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $982.02M, up 32.9% from the prior year and net income of -$416.30M. This page tracks Guardant Health, Inc. through 1,131 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Guardant Health, Inc.'s revenue grew from $25.25M to $982.02M, a compound annual growth rate of 50.2%. Net profit margin expanded from -182.7% to -42.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-20 |
We use cookies to improve your experience and remember your preferences. By clicking “Accept All”, you consent to our use of cookies. For more information, see our Privacy Policy and Cookie Policy.
We use cookies to improve your experience and remember your preferences. By clicking “Accept All”, you consent to our use of cookies. For more information, see our Privacy Policy and Cookie Policy.
We use cookies to improve your experience and remember your preferences. By clicking “Accept All”, you consent to our use of cookies. For more information, see our Privacy Policy and Cookie Policy.
We use cookies to improve your experience and remember your preferences. By clicking “Accept All”, you consent to our use of cookies. For more information, see our Privacy Policy and Cookie Policy.
The largest companies sharing Guardant Health, Inc.'s SEC industry classification (services-medical laboratories).
Guardant Health, Inc. (GH) has a market capitalization of $17.33 B as of 2026-06-10, ranking #671 among US-listed companies.
Guardant Health, Inc. reported revenue of $982.02M for fiscal year 2025, an increase of 32.9% year over year.
In its latest fiscal year Guardant Health, Inc. reported a net loss of $416.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
We use cookies to improve your experience and remember your preferences. By clicking “Accept All”, you consent to our use of cookies. For more information, see our Privacy Policy and Cookie Policy.